These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7502575)

  • 21. Sotalol-induced torsade de pointes: management with magnesium infusion.
    Arstall MA; Hii JT; Lehman RG; Horowitz JD
    Postgrad Med J; 1992 Apr; 68(798):289-90. PubMed ID: 1409197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Torsade de Pointes with T wave alternans in a patient receiving moderate dose of chlorpromazine: report of a case].
    Ochiai H; Kashiwagi M; Usui T; Oyama Y; Tokita Y; Ishikawa T
    Kokyu To Junkan; 1990 Aug; 38(8):819-22. PubMed ID: 2218093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
    Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
    Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.
    Badshah A; Mirza B; Janjua M; Nair R; Steinman RT; Cotant JF
    Hellenic J Cardiol; 2009; 50(3):224-6. PubMed ID: 19465366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Torsades de pointes with administration of high-dose intravenous d-sotalol to a patient with congestive heart failure.
    Gottlieb SS; Cines M; Marshall J
    Pharmacotherapy; 1997; 17(4):830-1. PubMed ID: 9250567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case series of sotalol-induced torsade de pointes in patients with atrial fibrillation--a tale with a twist.
    Tan HH; Hsu LF; Kam RM; Chua T; Teo WS
    Ann Acad Med Singap; 2003 May; 32(3):403-7. PubMed ID: 12854385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex difference in risk of torsade de pointes with d,l-sotalol.
    Lehmann MH; Hardy S; Archibald D; quart B; MacNeil DJ
    Circulation; 1996 Nov; 94(10):2535-41. PubMed ID: 8921798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes.
    Letsas KP; Efremidis M; Sideris A
    Int J Cardiol; 2008 Mar; 124(3):366-7; author reply 368-9. PubMed ID: 17400314
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of sotalol associated torsades de pointes tachycardia in a 15 month old child.
    Smith W
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):143. PubMed ID: 9990619
    [No Abstract]   [Full Text] [Related]  

  • 30. Amiodarone versus sotalol for atrial fibrillation.
    Zimetbaum PJ; Josephson ME
    N Engl J Med; 2005 Aug; 353(6):627-30; author reply 627-30. PubMed ID: 16094764
    [No Abstract]   [Full Text] [Related]  

  • 31. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.
    Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T
    Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical study of amiodarone-associated torsade de pointes in Chinese people.
    Geng DF; Jin DM; Wang JF; Luo YJ; Wu W
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):712-8. PubMed ID: 16884506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.
    Michiels V; Miljoen H; Vrints C
    Acta Cardiol; 2009 Dec; 64(6):839-42. PubMed ID: 20128168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Calmodulin antagonist inhibits torsade de pointes induced by d-sotalol in an isolated rabbit heart model].
    Pu J; Zhang CT; Bai R; Liu N; Li Y; Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):364-8. PubMed ID: 15932674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of the Risk of Torsades de Pointes in patients treated with intravenous racemic sotalol.
    Marill KA; Runge T
    Acad Emerg Med; 2001 Feb; 8(2):117-24. PubMed ID: 11157286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental study on the mechanism of sex difference in the risk of torsade de pointes.
    Ruan YF; Liu N; Zhou Q; Li Y; Wang L
    Chin Med J (Engl); 2004 Apr; 117(4):538-41. PubMed ID: 15109445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ['Cardiac ballet' with and without amiodarone].
    Balestra B; Hess T
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sotalol--atrial fibrillation, reduced renal function and sudden death].
    Bathen J; Madsen S
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4086-7. PubMed ID: 9844513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two cases of torsades de pointes caused by sotalol therapy.
    Cammu G; Geelen P; Baetens P; De Vos J; Demeyer I
    Resuscitation; 1999 Jan; 40(1):49-51. PubMed ID: 10321848
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
    Ophoff N; Toker Y
    Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.